Interactions between Alzheimer's disease and cerebral ischemia - Focus on inflammation

Brain Research Reviews

Volumn 48, Issue 2, 2005, Pages 240-250

  Koistinaho, Milla ^a,b   Koistinaho, Jari ^a,c  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b Cerebricon Limited   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Alzheimer's disease; Apolipoprotein E; Ischemia; Microglia; Neurodegeneration; Neuroinflammation

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 [4 (4 FLUOROPHENYL) 5 (2 METHOXY 4 PYRIMIDINYL) 1 IMIDAZOLYL] CYCLOHEXANOL; 4 [4 (4 FLUOROPHENYL) 5 (2 METHOXY 4 PYRIMIDINYL) 1 IMIDAZOLYL]CYCLOHEXANOL; ACETYLCHOLINE; ACETYLSALICYLIC ACID; AMINOGUANIDINE; AMPA RECEPTOR; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; AMYLOID PROTEIN; ANTICOAGULANT AGENT; ANTIINFLAMMATORY AGENT; APOLIPOPROTEIN; APOLIPOPROTEIN B; APOLIPOPROTEIN E; APOLIPOPROTEIN E EPSILON 3; APOLIPOPROTEIN E EPSILON 4; AUTACOID; CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE SUPPRESSIVE ANTIINFLAMMATORY AGENT; FIBRINOLYTIC AGENT; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NONSTEROID ANTIINFLAMMATORY AGENT; OLIGOMER; PYRIDINYLIMIDAZOLE; SD 282; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASODILATOR AGENT;

ALLELE; ALZHEIMER DISEASE; BRAIN HEMORRHAGE; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN REGION; CELL ACTIVATION; CELL MATURATION; CENTRAL NERVOUS SYSTEM FUNCTION; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; CONFERENCE PAPER; CYTOTOXICITY; DEMENTIA; DISEASE COURSE; ENCEPHALITIS; GENE OVEREXPRESSION; GLIA CELL; HUMAN; IN VIVO STUDY; INFLAMMATION; MEMORY DISORDER; MICROGLIA; MOLECULAR MECHANICS; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; STROKE; TREATMENT OUTCOME; UPREGULATION;

EID: 17844385791     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresrev.2004.12.014     Document Type: Conference Paper

References (159)

1. K. Abe, R.E. Tanzi, and K. Kogure Selective induction of Kunitz-type protease inhibitor domain containing amyloid precursor protein mRNA after persistent focal ischemia in rat cerebral cortex Neurosci. Lett. 125 1991 172 174
2. H. Akiyama, S. Barger, S. Barnum, B. Bradt, J. Bauer, G.M. Cole, N.R. Cooper, P. Eikelenboom, M. Emmerling, B.L. Fiebich, C.E. Finch, S. Frautschy, W.S. Griffin, H. Hampel, M. Hull, G. Landreth, L. Lue, R. Mrak, I.R. Mackenzie, P.L. McGeer, M.K. O'Banion, J. Pachter, G. Pasinetti, C. Plata-Salaman, J. Rogers, R. Rydel, Y. Shen, W. Streit, R. Strohmeyer, I. Tooyoma, F.L. Van Muiswinkel, R. Veerhuis, D. Walker, S. Webster, B. Wegrzyniak, G. Wenk, and T. Wyss-Coray Inflammation and Alzheimer's disease Neurobiol. Aging 21 2000 383 421
3. H. Akiyama, T. Arai, H. Kondo, E. Tanno, C. Haga, and K. Ikeda Cell mediators of inflammation in the Alzheimer disease brain Alzheimer Dis. Assoc. Disord. 14 2000 47 53
4. M.J. Alberts, C. Graffagnino, C. McClenny, D. DeLong, W. Strittmatter, A.M. Saunders, and A.D. Roses ApoE genotype and survival from intracerebral haemorrhage Lancet 346 1995 575
5. A.M. Badger, M.N. Cook, M.W. Lark, T.M. Newman-Tarr, B.A. Swift, A.H. Nelson, F.C. Barone, and S. Kumar SB 203580 inhibits p38 mitogen-activated protein kinase, nitric oxide production, and inducible nitric oxide synthase in bovine cartilage-derived chondrocytes J. Immunol. 161 1998 467 473
6. K.R. Bales, T. Verina, R.C. Dodel, Y. Du, L. Altstiel, M. Bender, P. Hyslop, E.M. Johnstone, S.P. Little, D.J. Cummins, P. Piccardo, B. Ghetti, and S.M. Paul Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition Nat. Genet. 17 1997 263 264
7. S.W. Barger, and A.D. Harmon Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E Nature 388 1997 878 881
8. F. Bard, C. Cannon, R. Barbour, R.L. Burke, D. Games, H. Grajeda, T. Guido, K. Hu, J. Huang, K. Johnson-Wood, K. Khan, D. Kholodenko, M. Lee, I. Lieberburg, R. Motter, M. Nguyen, F. Soriano, N. Vasquez, K. Weiss, B. Welch, P. Seubert, D. Schenk, and T. Yednock Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease Nat. Med. 6 2000 916 919
9. F.C. Barone, and G.Z. Feuerstein Inflammatory mediators and stroke: new opportunities for novel therapeutics J. Cereb. Blood Flow Metab. 19 1999 819 834
10. F.C. Barone, and A.A. Parsons Therapeutic potential of anti-inflammatory drugs in focal stroke Expert Opin. Invest. Drugs 9 2000 2281 2306
11. F.C. Barone, E.A. Irving, A.M. Ray, J.C. Lee, S. Kassis, S. Kumar, A.M. Badger, R.F. White, J. McVey, J.J. Legos, J.A. Erhardt, A.H. Nelson, E.H. Ohlstein, A.J. Hunter, K. Ward, B.R. Smith, J.L. Dams, and A.A. Parsons SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia Pharmacol. Exp. Ther. 296 2001 312 321
12. B. Becher, A. Prat, and J.P. Antel Brain-immune connection: immuno-regulatory properties of CNS-resident cells Glia 29 2000 293 304
13. N.R. Bhat, P. Zhang, J.C. Lee, and E.L. Hogan Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures J. Neurosci. 18 1998 1633 1641
14. M.M. Breteler Vascular risk factors for Alzheimer's disease: an epidemiologic perspective Neurobiol. Aging 21 2000 153 160
15. D.W. Busija, C. Thore, T. Beasley, and F. Bari Induction of cyclooxygenase-2 following anoxic stress in piglet cerebral arteries Microcirculation 3 1996 379 386
16. M.A. Chishti, D.S. Yang, C. Janus, A.L. Phinney, P. Horne, J. Pearson, R. Strome, N. Zuker, J. Loukides, J. French, S. Turner, G. Lozza, M. Grilli, S. Kunicki, C. Morissette, J. Paquette, F. Gervais, C. Bergeron, P.E. Fraser, G.A. Carlson, P.S. George-Hyslop, and D. Westaway Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695 J. Biol. Chem. 276 2001 21562 21570
17. J.R. Cirrito, P.C. May, M.A. O'Dell, J.W. Taylor, M. Parsadanian, J.W. Cramer, J.E. Audia, J.S. Nissen, K.R. Bales, S.M. Paul, R.B. DeMattos, and D.M. Holtzman In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-beta metabolism and half-life J. Neurosci. 23 2003 8844 8853
18. E.H. Corder, A.M. Saunders, W.J. Strittmatter, D.E. Schmechel, P.C. Gaskell, G.W. Small, A.D. Roses, J.L. Haines, and M.A. Pericak-Vance Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families Science 261 1993 921 923
19. G. del Zoppo, I. Ginis, J.M. Hallenbeck, C. Iadecola, X. Wang, and G.Z. Feuerstein Inflammation and troke: putative role for cytokines, adhesion molecules and iNOS in brain response toischemia Brain Pathol. 10 2000 95 112
20. R. D'Hooge, G. Nagels, C.E. Westland, L. Mucke, and P.P. De Deyn Spatial learning deficit in mice expressing human 751-amino acid beta-amyloid precursor protein NeuroReport 7 1996 2807 2811
21. U. Dirnagl, C. Iadecola, and M.A. Moskowitz Pathobiology of ischaemic stroke: an integrated view Trends Neurosci. 22 1999 391 397
22. J.C. Dodart, C. Mathis, K.R. Bales, S.M. Paul, and A. Ungerer Behavioral deficits in APP(V717F) transgenic mice deficient for the apolipoprotein E gene NeuroReport 11 2000 603 607
23. K. Duff Recent work on Alzheimer's disease transgenics Curr. Opin. Biotechnol. 9 1998 561 564
24. M.R. Farlow Alzheimer's disease: clinical implications of the apolipoprotein E genotype Neurology 48 1997 30 34
25. L. Ferrucci, J.M. Guralnik, M.E. Salive, M. Pahor, M.C. Corti, A. Baroni, and R.J. Havlik Cognitive impairment and risk of stroke in the older population J. Am. Geriatr. Soc. 44 1996 237 241
26. C.R. Gale, C.N. Martyn, and C. Cooper Cognitive impairment and mortality in a cohort of elderly people Br. Med. J. 312 1996 608 611
27. D. Giulian, L.J. Haverkamp, J. Li, W.L. Karshin, J. Yu, D. Tom, X. Li, and J.B. Kirkpatrick Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brain Neurochem. Int. 1 1995 119 137
28. D. Giulian Microglia and the immune pathology of Alzheimer disease Am. J. Hum. Genet. 65 1999 13 18
29. J. Hardy The Alzheimer family of diseases: many etiologies, one pathogenesis? Proc. Natl. Acad. Sci. U. S. A. 94 1997 2095 2097
30. J.A. Hardy, and G.A. Higgins Alzheimer's disease: the amyloid cascade hypothesis Science 256 1992 184 185
31. A. Heyman, G.G. Fillenbaum, K.A. Welsh-Bohmer, M. Gearing, S.S. Mirra, R.C. Mohs, B.L. Peterson, and C.F. Pieper Cerebral infarcts in patients with autopsy-proven Alzheimer's disease: CERAD, part XVIII. Consortium to establish a registry for Alzheimer's disease Neurology 51 1998 159 162
32. L.S. Higgins, D.M. Holtzman, J. Rabin, W.C. Mobley, and B. Cordell Transgenic mouse brain histopathology resembles early Alzheimer's disease Ann. Neurol. 35 1994 598 607
33. L.S. Higgins, J.M. Rodems, R. Catalano, D. Quon, and B. Cordell Early Alzheimer disease-like histopathology increases in frequency with age in mice transgenic for beta-APP751 Proc. Natl. Acad. Sci. U. S. A. 92 1995 4402 4406
34. K. Horsburgh, and J.A. Nicoll Selective alterations in the cellular distribution of apolipoprotein E immunoreactivity following transient cerebral ischaemia in the rat Neuropathol. Appl. Neurobiol. 22 1996 342 349
35. K. Horsburgh, and J.A. Nicoll Selective cellular alterations in amyloid precursor protein and apolipoprotein E after transient global ischaemia in the rat Alzheimer Res. 2 1996 37 42
36. K. Horsburgh, M. Fitzpatrick, M. Nilsen, and J.A. Nicoll Marked alterations in the cellular localization and levels of apolipoprotein E following acute subdural haematoma in rat Brain Res. 763 1997 103 110
37. K. Horsburgh, D.I. Graham, J. Stewart, and J.A. Nicoll Influence of apolipoprotein E genotype on neuronal damage and apoE immunoreactivity in human hippocampus following global ischemia J. Neuropathol. Exp. Neurol. 58 1999 227 234
38. K. Horsburgh, S. Kelly, J. McCulloch, G.A. Higgins, A.D. Roses, and J.A. Nicoll Increased neuronal damage in apolipoprotein E-deficient mice following global ischaemia NeuroReport 10 1999 837 841
39. K. Horsburgh, S. Kelly, J. McCulloch, G.A. Higgins, A.D. Roses, and J.A. Nicoll The role of apolipoprotein E in Alzheimer's disease, acute brain injury and cerebrovascular disease: evidence of common mechanisms and utility of animal models Neurobiol. Aging 21 2000 245 255
40. K. Horsburgh, J. McCulloch, M. Nilsen, A.D. Roses, and J.A. Nicoll Increased neuronal damage and apoE immunoreactivity in human apolipoprotein E, E4 isoform-specific, transgenic mice after global cerebral ischaemia Eur. J. Neurosci. 12 2000 4309 4317
41. A.Y. Hsia, E. Masliah, L. McConlogue, G.Q. Yu, G. Tatsuno, K. Hu, D. Kholodenko, R.C. Malenka, R.A. Nicoll, and L. Mucke Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models Proc. Natl. Acad. Sci. U. S. A. 96 1999 3228 3233
42. K.K. Hsiao, D.R. Borchelt, K. Olson, R. Johannsdottir, C. Kitt, W. Yunis, S. Xu, C. Eckman, S. Younkin, D. Price, C. Iadecola, H.B. Clark, and G. Carlson Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins Neuron 15 1995 1203 1218
43. A. Hofman, A. Ott, M.M. Breteler, M.L. Bots, A.J. Slooter, F. van Harskamp, C.N. van Duijn, C. Van Broeckhoven, and D.E. Grobbee Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study Lancet 349 1997 151 154
44. L.A. Holcomb, M.N. Gordon, P. Jantzen, K. Hsiao, K. Duff, and D. Morgan Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: lack of association with amyloid deposits Behav. Genet. 29 1999 177 185
45. M. Hosokawa, A. Klegeris, J. Maguire, and P.L. McGeer Expression of complement messenger RNAs and proteins by human oligodendroglial cells Glia 42 2003 417 423
46. C. Iadecola, F. Zhang, and X. Xu Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage Am. J. Physiol. 268 1995 286 292
47. C. Iadecola, and M.E. Ross Molecular pathology of cerebral ischemia: delayed gene expression and strategies for neuroprotection Ann. N. Y. Acad. Sci. 835 1997 203 217
48. C. Iadecola, F. Zhang, R. Casey, M. Nagayama, and M.E. Ross Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene J. Neurosci. 17 1997 9157 9164
49. C. Iadecola, C. Forster, S. Nogawa, H.B. Clark, and M.E. Ross Cyclooxygenase-2 immunoreactivity in the human brain following cerebral ischemia Acta Neuropathol. (Berl). 98 1999 9 14
50. C. Iadecola, F. Zhang, K. Niwa, C. Eckman, S.K. Turner, E. Fischer, S. Younkin, D.R. Borchelt, K.K. Hsiao, and G.A. Carlson SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein Nat. Neurosci. 2 1999 157 161
51. P.T. Jantzen, K.E. Connor, G. DiCarlo, G.L. Wenk, J.L. Wallace, A.M. Rojiani, D. Coppola, D. Morgan, and M.N. Gordon Microglial activation and beta-amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus presenilin-1 transgenic mice J. Neurosci. 22 2002 2246 2254
52. S.A. Johnson, T. McNeill, B. Cordell, and C.E. Finch Relation of neuronal APP-751/APP-695 mRNA ratio and neuritic plaque density in Alzheimer's disease Science 248 1990 854 857
53. R.N. Kalaria Cerebral vessels in ageing and Alzheimer's disease Pharmacol. Ther. 72 1996 193 214
54. R.N. Kalaria Microglia and Alzheimer's disease Curr. Opin. Hematol. 6 1999 15 24
55. R.N. Kalaria The role of cerebral ischemia in Alzheimer's disease Neurobiol. Aging 21 2000 321 330
56. R.N. Kalaria, S.U. Bhatti, W.D. Lust, and G. Perry The amyloid precursor protein in ischemic brain njury and chronic hypoperfusion Ann. N. Y. Acad. Sci. 695 1993 190 193
57. H. Kamada, K. Sato, W.R. Zhang, N. Omori, I. Nagano, M. Shoji, and K. Abe Spatiotemporal changes of apolipoprotein E immunoreactivity and apolipoprotein E mRNA expression after transient middle cerebral artery occlusion in rat brain J. Neurosci. Res. 73 2003 545 556
58. J. Kang, H.G. Lemaire, A. Unterbeck, J.M. Salbaum, C.L. Masters, K.H. Grzeschik, G. Multhaup, K. Beyreuther, and B. Muller-Hill The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor Nature 325 1987 733 736
59. T. Kawarabayashi, M. Shoji, L.H. Younkin, L. Wen-Lang, D.W. Dickson, T. Murakami, E. Matsubara, K. Abe, K.H. Ashe, and S.G. Younkin Dimeric amyloid beta protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer's disease J. Neurosci. 24 2004 3801 3809
60. R. Kayed, E. Head, J.L. Thompson, T.M. McIntire, S.C. Milton, C.W. Cotman, and C.G. Glabe Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis Science 300 2003 486 489
61. H.J. Kim, S.C. Chae, D.K. Lee, B. Chromy, S.C. Lee, Y.C. Park, W.L. Klein, G.A. Krafft, and S.T. Hong Selective neuronal degeneration induced by soluble oligomeric amyloid beta protein FASEB J. 17 2003 118 120
62. N. Kitaguchi, Y. Takahashi, Y. Tokushima, S. Shiojiri, and H. Ito Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitor activity Nature 331 1998 530 532
63. W.L. Klein, G.A. Krafft, and C.E. Finch Targeting small Aβ oligomers: the solution to an Alzheimer's disease conundrum? Trends Neurosci. 24 2001 219 224
64. M. Koistinaho, M. Ort, J.M. Cimadevilla, R. Vondrous, B. Cordell, J. Koistinaho, J. Bures, and L.S. Higgins Specific spatial learning deficits become severe with age in beta-amyloid precursor protein transgenic mice that harbor diffuse beta-amyloid deposits but do not form plaques Proc. Natl. Acad. Sci. U. S. A. 98 2001 14675 14680
65. M. Koistinaho, M.I. Kettunen, G. Goldsteins, R. Keinanen, A. Salminen, M. Ort, J. Bures, D. Liu, R.A. Kauppinen, L.S. Higgins, and J. Koistinaho Beta-amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ischemic vulnerability: role of inflammation Proc. Natl. Acad. Sci. U. S. A. 99 2002 1610 1615
66. M. Koistinaho, M.I. Kettunen, D.M. Holtzman, R.A. Kauppinen, L.S. Higgins, and J. Koistinaho Expression of human apolipoprotein E downregulates amyloid precursor protein-induced ischemic susceptibility Stroke 33 2002 1905 1910
67. M. Koistinaho, S. Lin, X. Wu, M. Esterman, D. Koger, J. Hanson, R. Higgs, F. Liu, S. Malkani, K.R. Bales, and S.M. Paul Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-β peptides Nat. Med. 10 2004 719 726
68. E. Kokmen, J.P. Whisnant, W.M. O'Fallon, C.P. Chu, and C.M. Beard Dementia after ischemic stroke: a population-based study in Rochester, Minnesota (1960-1984) Neurology 46 1996 154 159
69. T. Kristian, and B.K. Siesjo Calcium in ischemic cell death Stroke 29 1998 705 718
70. S. Kumar, P.C. McDonnell, R.J. Gum, A.T. Hand, J.C. Lee, and P.R. Young Novel homologues of CSBP/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles Biochem. Biophys. Res. Commun. 235 1997 533 538
71. J.L. Kummer, P.K. Rao, and K.A. Heidenreich Apoptosis induced by withdrawal of trophic factors is mediated by p38 mitogen-activated protein kinase J. Biol. Chem. 272 1997 20490 20494
72. J. Larson, G. Lynch, D. Games, and P. Seubert Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP mice Brain Res. 840 1999 23 35
73. D.T. Laskowitz, H. Sheng, R.D. Bart, K.A. Joyner, A.D. Roses, and D.S. Warner Apolipoprotein E deficient mice have increased susceptibility to focal cerebral ischemia J. Cereb. Blood Flow Metab. 17 1997 753 758
74. D.T. Laskowitz, A.D. Thekdi, S.D. Thekdi, S.K. Han, J.K. Myers, S.V. Pizzo, and E.R. Bennett Downregulation of microglial activation by apolipoprotein E and apoE-mimetic peptides Exp. Neurol. 167 2001 74 85
75. J.C. Lee, A.M. Badger, D.E. Griswold, D. Dunnington, A. Truneh, B. Votta, J.R. White, P.R. Young, and P.E. Bender Bicyclic imidazoles as a novel class of cytokine biosynthesis inhibitors Ann. N. Y. Acad. Sci. 696 1993 149 170
76. J.C. Lee, J.T. Laydon, P.C. McDonnell, T.F. Gallagher, S. Kumar, D. Green, D. McNulty, M.J. Blumentha, J.R. Heys, S.W. Landvatter, S.E. Strickler, M.M. McLaughlin, I. Seimens, S. Fisher, G.B. Livi, J.R. White, J.L. Adams, and P.R. Young A protein kinase involved in the regulation of inflammatory cytokine biosynthesis Nature 372 1994 739 746
77. J.J. Legos, J.A. Erhardt, R.F. White, S.C. Lenhard, S. Chandra, A.A. Parsons, R.F. Tuma, and F.C. Barone SB 239063, a novel p38 inhibitor, attenuates early neuronal injury following ischemia Brain Res. 892 2001 70 77
78. G.P. Lim, F. Yang, T. Chu, P. Chen, W. Beech, B. Teter, T. Tran, O. Ubeda, K.H. Ashe, S.A. Frautschy, and G.M. Cole Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease J. Neurosci. 20 2000 5709 5714
79. D.T. Loo, A. Copani, C.J. Pike, E.R. Whittemore, A.J. Walencewicz, and C.W. Cotman Apoptosis is induced by beta-amyloid in cultured central nervous system neurons Proc. Natl. Acad. Sci. U. S. A. 90 1993 7951 7955
80. J.R. Lynch, D. Morgan, J. Mance, W.D. Matthew, and D.T. Laskowitz Apolipoprotein E modulates glial activation and the endogenous central nervous system inflammatory response J. Neuroimmunol. 114 2001 107 113
81. R.W. Mahley Apolipoprotein E: cholesterol transport protein with expanding role in cell biology Science 240 1988 622 630
82. R.L. Martin, H.G. Lloyd, and A.I. Cowan The early events of oxygen and glucose deprivation: setting the scene for neuronal death? Trends Neurosci. 17 1994 251 257
83. M.P. Mattson, B. Cheng, A.R. Culwell, F.S. Esch, I. Lieberburg, and R.E. Rydel Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor protein Neuron 10 1993 243 254
84. M.P. Mattson, S.W. Barger, K. Furukawa, A.J. Bruce, T. Wyss-Coray, R.J. Mark, and L. Mucke Cellular signaling roles of TGF beta, TNF alpha and beta APP in brain injury responses and Alzheimer's disease Brain Res. Brain Res. Rev. 23 1997 47 61
85. P.L. McGeer, M. Schulzer, and E.G. McGeer Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies Neurology 47 1996 425 432
86. D.R. McDonald, M.E. Bamberger, C.K. Combs, and G.E. Landreth Beta-amyloid fibrils activate parallel mitogen-activated protein kinase pathways in microglia and THP1 monocytes J. Neurosci. 18 1998 4451 4460
87. C.A. McLean, R.A. Cherny, F.W. Fraser, S.J. Fuller, M.J. Smith, K. Beyreuther, A.I. Bush, and C.L. Masters Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease Ann. Neurol. 46 1999 860 866
88. L. Meda, M.A. Cassatella, G.I. Szendrei, L. Otvos Jr., P. Baron, M. Villalba, and D. Ferrari Activation of microglial cells by beta-amyloid protein and interferon-gamma Nature 374 1995 647 650
89. S. Miettinen, F.R. Fusco, J. Yrjanheikki, R. Keinanen, T. Hirvonen, R. Roivainen, M. Narhi, T. Hokfelt, and J. Koistinaho Spreading depression and focal brain ischemia induce cyclooxygenase-2 in cortical neurons through N-methyl-d-aspartic acid-receptors and phospholipase A2 Proc. Natl. Acad. Sci. U. S. A. 94 1997 6500 6505
90. P.M. Moran, L.S. Higgins, B. Cordell, and P.C. Moser Age-related learning deficits in transgenic mice expressing the 751-amino acid isoform of human beta-amyloid precursor protein Proc. Natl. Acad. Sci. U. S. A. 92 1995 5341 5345
91. Z. Nagy, M.M. Esiri, K.A. Jobst, J.H. Morris, E.M. King, B. McDonald, S. Litchfield, A. Smith, L. Barnetson, and A.D. Smith Relative roles of plaques and tangles in the dementia of Alzheimer's disease: correlations using three sets of neuropathological criteria Dementia 6 1995 21 31
92. Z. Nagy, M.M. Esiri, K.A. Jobst, J.H. Morris, E.M. King, B. McDonald, C. Joachim, S. Litchfield, L. Barnetson, and A.D. Smith The effects of additional pathology on the cognitive deficit in Alzheimer disease J. Neuropathol. Exp. Neurol. 56 1997 165 170
93. R.L. Neve, and N.K. Robakis Alzheimer's disease: a re-examination of the amyloid hypothesis Trends Neurosci. 21 1998 15 19
94. R.L. Neve, D.L. McPhie, and Y. Chen Alzheimer's disease: a dysfunction of the amyloid precursor protein Brain Res. 886 2000 54 66
95. K. Niwa, G.A. Carlson, and C. Iadecola Exogenous A beta1-40 reproduces cerebrovascular alterations resulting from amyloid precursor protein overexpression in mice J. Cereb. Blood Flow Metab. 20 2000 1659 1668
96. K. Niwa, K. Kazama, L. Younkin, S.G. Younkin, G.A. Carlson, and C. Iadecola Cerebrovascular autoregulation is profoundly impaired in mice overexpressing amyloid precursor protein Am. J. Physiol.: Heart Circ. Physiol. 283 2002 315 323
97. A. Ott, M.M. Breteler, M.C. de Bruyne, F. van Harskamp, D.E. Grobbee, and A. Hofman Atrial fibrillation and dementia in a population-based study. The Rotterdam Study Stroke 28 1997 316 321
98. P.K. Panegyres The functions of the amyloid precursor protein gene Rev. Neurosci. 12 2001 1 39
99. D. Paris, T. Town, T. Mori, T.A. Parker, J. Humphrey, and M. Mullan Soluble beta amyloid peptides mediate vasoactivity via activation of a pro-inflammatory pathway Neurobiol. Aging 21 2000 183 197
100. D. Paris, J. Humphrey, A. Quadros, N. Patel, R. Crescentini, F. Crawford, and M. Mullan Vasoactive effects of A beta in isolated human cerebrovessels and in a transgenic mouse model of Alzheimer's disease: role of inflammation Neurol. Res. 25 2003 642 651
101. D. Paris, A. Quadros, J. Humphrey, N. Patel, R. Crescentini, F. Crawford, and M. Mullan Nilvadipine antagonizes both Abeta vasoactivity in isolated arteries, and the reduced cerebral blood flow in APPsw transgenic mice Brain Res. 999 2004 53 61
102. F. Pasquier, D. Leys, and P. Scheltens The influence of coincidental vascular pathology on symptomatology and course of Alzheimer's disease J. Neural Transm., Suppl. 54 1998 117 127
103. R.G. Perez, H. Zheng, L.H. Van der Ploeg, and E.H. Koo The beta-amyloid precursor protein of Alzheimer's disease enhances neuron viability and modulates neuronal polarity J. Neurosci. 17 1997 9407 9414
104. W.H. Perry, and S. Gordon Macrophages and the nervous system Int. Rev. Cytol. 125 1991 203 244
105. M. Pitschke, R. Prior, M. Haupt, and D. Riesner Detection of single amyloid beta-protein aggregates in the cerebrospinal fluid of Alzheimer's patients by fluorescence correlation spectroscopy Nat. Med. 4 1998 832 834
106. J. Poirier Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease Trends Neurosci. 17 1994 525 530
107. P. Ponte, P. Gonzalez-DeWhitt, J. Schilling, J. Miller, D. Hsu, B. Greenberg, K. Davis, W. Wallace, I. Lieberburg, and F. Fuller A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors Nature 331 1988 525 527
108. D.R. Premkumar, D.L. Cohen, P. Hedera, R.P. Friedland, and R.N. Kalaria Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease Am. J. Pathol. 148 1996 2083 2095
109. D. Price, R. Tanzi, D.R. Borchelt, and S. Sisodia Alzheimer's disease: genetic studies and transgenic models Annu. Rev. Genet. 32 1998 461 493
110. D. Quon, Y. Wang, R. Catalano, J.M. Scardina, K. Murakami, and B. Cordell Formation of beta-amyloid protein deposits in brains of transgenic mice Nature 352 1991 239 241
111. C.H. Rojas-Fernandez, M. Chen, and H.L. Fernandez Implications of amyloid precursor protein and subsequent beta-amyloid production to the pharmacotherapy of Alzheimer's disease Pharmacotherapy 22 2002 1547 1563
112. A.D. Roses Apolipoprotein E and Alzheimer's disease. The tip of the susceptibility iceberg Ann. N. Y. Acad. Sci. 855 1998 738 743
113. N. Rothwell Interleukin-1 and neuronal injury: mechanisms, modification, and therapeutic potential Brain Behav. Immun. 17 2003 152 157
114. T.C. Saido, M. Yokota, K. Maruyama, W. Yamao-Harigaya, E. Tani, Y. Ihara, and S. Kawashima Spatial resolution of the primary beta-amyloidogenic process induced in postischemic hippocampus J. Biol. Chem. 69 1994 15253 15257
115. T. Sairanen, O. Carpen, M.L. Karjalainen-Lindsberg, A. Paetau, U. Turpeinen, M. Kaste, and P.J. Lindsberg Evolution of cerebral tumor necrosis factor-alpha production during human ischemic stroke Stroke 32 2001 1750 1758
116. A.M. Saunders, W.J. Strittmatter, D. Schmechel, P.H. George-Hyslop, M.A. Pericak-Vance, S.H. Joo, B.L. Rosi, J.F. Gusella, D.R. Crapper-MacLachlan, M.J. Alberts, C. Hulette, B. Crain, D. Goldraber, and A.D. Roses Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease Neurology 43 1993 1467 1472
117. D.E. Schmechel, A.M. Saunders, W.J. Strittmatter, B.J. Crain, C.M. Hulette, S.H. Joo, M.A. Pericak-Vance, D. Goldgaber, and A.D. Roses Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease Proc. Natl. Acad. Sci. U. S. A. 90 1993 9649 9653
118. D.J. Selkoe Normal and abnormal biology of the beta-amyloid precursor protein Annu. Rev. Neurosci. 17 1994 489 517
119. D.J. Selkoe Translating cell biology into therapeutic advances in Alzheimer's disease Nature 399 1999 23 31
120. D.J. Selkoe Alzheimer's disease: genes, proteins and therapy Physiol. Rev. 81 2001 741 765
121. J. Sharkey, J.S. Kelly, and S.P. Butcher Inflammatory responses to cerebral ischemia G.J. Horst J. Korf Clinical Pharmacology of Cerebral Ischemia 1997 Humana Press Totowa, NJ 235 265
122. H. Sheng, D.T. Laskowitz, E. Bennett, D.E. Schmechel, R.D. Bart, A.M. Saunders, R.D. Pearlstein, A.D. Roses, and D.S. Warner Apolipoprotein E isoform-specific differences in outcome fromfocal ischemia in transgenic mice J. Cereb. Blood Flow Metab. 18 1998 361 366
123. H. Sheng, D.T. Laskowitz, G.B. Mackensen, M. Kudo, R.D. Pearlstein, and D.S. Warner Apolipoprotein E deficiency worsens outcome from global cerebral ischemia in the mouse Stroke 30 1999 1118 1124
124. B.K. Siesjö Pathophysiology and treatment of focal cerebral ischemia, Part II: Mechanisms of damage and treatment J. Neurosurg. 77 1992 337 354
125. B.K. Siesjö A new perspective on ischemic brain damage? Prog. Brain Res. 96 1993 1 9
126. I. Skoog, B. Lernfelt, S. Landahl, B. Palmertz, L.A. Andreasson, L. Nilsson, G. Persson, A. Oden, and A. Svanborg 15-year longitudinal study of blood pressure and dementia Lancet 347 1996 1141 1145
127. A.J. Slooter, M.X. Tang, C.M. van Duijn, Y. Stern, A. Ott, K. Bell, M.M. Breteler, C. Van Broeckhoven, T.K. Tatemichi, B. Tycko, A. Hofman, and R. Mayeux Apolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigation JAMA 277 1997 818 821
128. H.H. Slunt, G. Thinakaran, C. Von Koch, A.C. Lo, R.E. Tanzi, and S.S. Sisodia Expression of a ubiquitous, cross-reactive homologue of the mouse beta-amyloid precursor protein (APP) J. Biol. Chem. 269 1994 2637 2644
129. V.L. Smith-Swintosky, L.C. Pettigrew, S.D. Craddock, A.R. Culwell, R.E. Rydel, and M.P. Mattson Secreted forms of beta-amyloid precursor protein protect against ischemic brain injury J. Neurochem. 63 1994 781 784
130. D.A. Snowdon, L.H. Greiner, J.A. Mortimer, K.P. Riley, P.A. Greiner, and W.R. Markesbery Brain infarction and the clinical expression of Alzheimer disease. The Nun Study JAMA 277 1997 813 817
131. B. Sommer Alzheimer's disease and the amyloid cascade hypothesis: ten years on Curr. Opin. Pharmacol. 2 2002 87 92
132. C.M. Sondag, and C.K. Combs Amyloid precursor protein mediates proinflammatory activation of monocytic lineage cells J. Biol. Chem. 279 2004 14456 14463
133. I. Sponne, A. Fifre, B. Kriem, V. Koziel, B. Bihain, T. Oster, J.L. Olivier, and T. Pillot Membrane cholesterol interferes with neuronal apoptosis induced by soluble oligomers but not fibrils of the amyloid-beta peptide FASEB J. 18 2004 836 838
134. D.T. Stephenson, K. Rash, and J.A. Clemens Amyloid precursor protein accumulates in regions of neurodegeneration following focal cerebral ischemia in the rat Brain Res. 593 1992 128 135
135. G. Stoll, S. Jander, and M. Schroeter Inflammation and glial responses in ischemic brain lesions Prog. Neurobiol. 56 1998 149 171
136. W.J. Strittmatter, A.M. Saunders, D. Schmechel, M. Pericak-Vance, J. Enghild, G.S. Salvesen, and A.D. Roses Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease Proc. Natl. Acad. Sci. U. S. A. 90 1993 1977 1981
137. T. Sugino, K. Nozaki, Y. Takagi, I. Hattori, N. Hashimoto, T. Moriguchi, and E. Nishida Activation of mitogen-activated protein kinases after transient forebrain ischemia in gerbil hippocampus J. Neurosci. 20 2000 4506 4514
138. Y.H. Suh, and F. Checler Amyloid precursor protein, presenilins, and alpha-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer's disease Pharmacol. Rev. 54 2002 469 525
139. M. Takahashi, S. Dore, C.D. Ferris, T. Tomita, A. Sawa, H. Wolosker, D.R. Borchelt, T. Iwatsubo, S.H. Kim, G. Thinakaran, S.S. Sisodia, and S.H. Snyder Amyloid precursor proteins inhibit heme oxygenase activity and augment neurotoxicity in Alzheimer's disease Neuron 28 2000 461 473
140. J. Tan, T. Town, Z. Suo, Y. Wu, S. Song, A. Kundtz, J. Kroeger, J. Humphrey, F. Crawford, and M. Mullan Induction of CD40 on human endothelial cells by Alzheimer's beta-amyloid peptides Brain Res. Bull. 50 1999 143 148
141. R.E. Tanzi, A.I. McClatchey, E.D. Lamperti, L. Villa-Komaroff, J.F. Gusella, and R.L. Neve Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease Nature 331 1988 528 530
142. G.M. Teasdale, J.A. Nicoll, G. Murray, and M. Fiddes Association of apolipoprotein E polymorphism with outcome after head injury Lancet 350 1997 1069 1071
143. U. Thaker, A.M. McDonagh, T. Iwatsubo, C.L. Lendon, S.M. Pickering-Brown, and D.M. Mann Tau load is associated with apolipoprotein E genotype and the amount of amyloid beta protein, Abeta40, in sporadic and familial Alzheimer's disease Neuropathol. Appl. Neurobiol. 29 2003 35 44
144. K.P. Townsend, D. Obregon, A. Quadros, N. Patel, C. Volmar, D. Paris, and M. Mullan Proinflammatory and vasoactive effects of Abeta in the cerebrovasculature Ann. N. Y. Acad. Sci. 977 2002 65 76
145. F.L. vanMuiswinkel, S.F. Raupp, N.M. de Vos, H.A. Smits, J. Verhoef, P. Eikelenboom, and H.S. Nottet The amino-terminus of the amyloid-beta protein is critical for the cellular binding and consequent activation of the respiratory burst of human macrophages J. Neuroimmunol. 96 1999 121 130
146. S. Weggen, J.L. Eriksen, P. Das, S.A. Sagi, R. Wang, C.U. Pietrzik, K.A. Findlay, T.E. Smith, M.P. Murphy, T. Bulter, D.E. Kang, N. Marquez-Sterling, T.E. Golde, and E.H. Koo A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity Nature 414 2001 212 216
147. Y. Wen, O. Onyewuchi, S. Yang, R. Liu, and J.W. Simpkins Increased beta-secretase activity and expression in rats following transient cerebral ischemia Brain Res. 1009 2004 1 8
148. Y. Wen, S. Yang, R. Liu, A.M. Brun-Zinkernagel, P. Koulen, and J.W. Simpkins Transient cerebral ischemia induces aberrant neuronal cell cycle reentry and Alzheimer's disease-like tauopathy in female rats J. Biol. Chem. 279 2004 22684 22692
149. P.A. Wolf, J.L. Cobb, and R.B. D'Agostino H.J.M. Barnett J.P. Mohr B.M. Stein F.M. Yatsu Stroke, Pathophysiology, Diagnosis and Management 1997 Churchill Livingstone New York 3 27
150. T. Wyss-Coray, J.D. Loike, T.C. Brionne, E. Lu, R. Anankov, F. Yan, S.C. Silverstein, and J. Husemann Adult mouse astrocytes degrade amyloid-beta in vitro and in situ Nat. Med. 9 2003 453 457
151. M. Yokota, T.C. Saido, E. Tani, I. Yamaura, and N. Minami Cytotoxic fragment of amyloid precursor protein accumulates in hippocampus after global forebrain ischemia J. Cereb. Blood Flow Metab. 16 1996 1219 1223
152. P. Young, P. McDonnell, D. Dunnington, A. Hand, J. Laydon, and J. Lee Pyridinyl imidazoles inhibit IL-1 and TNF production at the protein level Agents Actions 39 1993 67 69
153. J. Yrjänheikki, R. Keinänen, M. Pellikka, T. Hökfelt, and J. Koistinaho Tetracyclines inhibit microglial ctivation and are neuroprotective in global brain ischemia Proc. Natl. Acad. Sci. U. S. A. 5 1998 15769 15774
154. J. Yrjänheikki, T. Tikka, R. Keinänen, G. Goldsteins, P.H. Chan, and J. Koistinaho A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window Proc. Natl. Acad. Sci. U. S. A. 96 1999 13496 13500
155. C.V. Zerbinatti, D.F. Wozniak, J. Cirrito, J.A. Cam, H. Osaka, K.R. Bales, M. Zhuo, S.M. Paul, D.M. Holtzman, and G. Bu Increased soluble amyloid-beta peptide and memory deficits in amyloid model mice overexpressing the low-density lipoprotein receptor-related protein Proc. Natl. Acad. Sci. U. S. A. 101 2004 1075 1080
156. F. Zhang, C. Eckman, S. Younkin, K.K. Hsiao, and C. Iadecola Increased susceptibility to ischemic brain damage in transgenic mice overexpressing the amyloid precursor protein J. Neurosci. 17 1997 7655 7661
157. H. Zheng, M. Jiang, M.E. Trumbauer, D.J. Sirinathsinghji, R. Hopkins, D.W. Smith, R.P. Heavens, G.R. Dawson, S. Boyce, M.W. Conner, S. Sisodia, and L. Van der Ploeg β-Amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity Cell 81 1995 525 531
158. H. Zheng, M. Jiang, M.E. Trumbauer, R. Hopkins, D.J. Sirinathsinghji, K.A. Stevens, M.W. Conner, H.H. Slunt, S.S. Sisodia, H.Y. Chen, and L.H. Van der Ploeg Mice deficient for the amyloid precursor protein gene Ann. N. Y. Acad. Sci. 777 1996 421 426
159. Y. Zhou, Y. Su, B. Li, F. Liu, J.W. Ryder, X. Wu, P.A. Gonzalez-DeWhitt, V. Gelfanova, J.E. Hale, P.M. May, S.M. Paul, and B. Ni Nonsteroidal anti-inflammatory drugs can lower amyloidogenic Abeta42 by inhibiting Rho Science 302 2003 1215 1217